200,000+ products from a single source!
sales@angenechem.com
157286-86-7 | 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-butyl-N-ethyl-2,5-dimethyl-7-(2,4,6-trimethylphenyl)-
CAS No: 157286-86-7 Catalog No: AG001PCV MDL No:
Product Description
Catalog Number:
AG001PCV
Chemical Name:
7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-butyl-N-ethyl-2,5-dimethyl-7-(2,4,6-trimethylphenyl)-
CAS Number:
157286-86-7
Molecular Formula:
C23H32N4
Molecular Weight:
364.5270
IUPAC Name:
N-butyl-N-ethyl-2,5-dimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-amine
InChI:
InChI=1S/C23H32N4/c1-8-10-11-26(9-2)22-20-18(6)14-27(23(20)25-19(7)24-22)21-16(4)12-15(3)13-17(21)5/h12-14H,8-11H2,1-7H3
InChI Key:
FHQYJZCJRZHINA-UHFFFAOYSA-N
SMILES:
CCCCN(c1nc(C)nc2c1c(C)cn2c1c(C)cc(cc1C)C)CC
UNII:
9A549FB00R
Properties
Complexity:
457
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
364.263g/mol
Formal Charge:
0
Heavy Atom Count:
27
Hydrogen Bond Acceptor Count:
3
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
364.537g/mol
Monoisotopic Mass:
364.263g/mol
Rotatable Bond Count:
6
Topological Polar Surface Area:
34A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
6.2
Literature
| Title | Journal |
|---|---|
| Cardiac adverse effects of naloxone-precipitated morphine withdrawal on right ventricle: role of corticotropin-releasing factor (CRF) 1 receptor. | Toxicology and applied pharmacology 20140215 |
| Lifelong CRF overproduction is associated with altered gene expression and sensitivity of discrete GABA(A) and mGlu receptor subtypes. | Psychopharmacology 20120201 |
| Effects of acute stress on acquisition of nicotine conditioned place preference in adolescent rats: a role for corticotropin-releasing factor 1 receptors. | Psychopharmacology 20120101 |
| Role of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc). | PloS one 20120101 |
| Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA. | Psychopharmacology 20111101 |
| α(2) Adrenergic and imidazoline receptor agonists prevent cue-induced cocaine seeking. | Biological psychiatry 20111015 |
| Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist. | Journal of medicinal chemistry 20110623 |
| Discovery of pyrrolo[2,3-d]pyrimidin-4-ones as corticotropin-releasing factor 1 receptor antagonists with a carbonyl-based hydrogen bonding acceptor. | Bioorganic & medicinal chemistry letters 20110415 |
| Blocking corticotropin-releasing factor-2 receptors, but not corticotropin-releasing factor-1 receptors or glucocorticoid feedback, disrupts the development of conditioned defeat. | Physiology & behavior 20101102 |
| Stress-induced priming of glutamate synapses unmasks associative short-term plasticity. | Nature neuroscience 20101001 |
| Pain is a salient 'stressor' that is mediated by corticotropin-releasing factor-1 receptors. | Neuropharmacology 20100901 |
| CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100501 |
| The alarm pheromone in male rats as a unique anxiety model: psychopharmacological evidence using anxiolytics. | Pharmacology, biochemistry, and behavior 20100201 |
| Social subordination and polymorphisms in the gene encoding the serotonin transporter enhance estradiol inhibition of luteinizing hormone secretion in female rhesus monkeys. | Biology of reproduction 20091201 |
| The alcohol deprivation effect in C57BL/6J mice is observed using operant self-administration procedures and is modulated by CRF-1 receptor signaling. | Alcoholism, clinical and experimental research 20090101 |
| A comparison of ligand based virtual screening methods and application to corticotropin releasing factor 1 receptor. | Journal of molecular graphics & modelling 20090101 |
| Corticotropin-releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20081001 |
| 2-Arylpyrimidines: novel CRF-1 receptor antagonists. | Bioorganic & medicinal chemistry letters 20080815 |
| Corticotropin-releasing hormone receptor 1 coexists with endothelin-1 and modulates its mRNA expression and release in rat paraventricular nucleus during hypoxia. | Neuroscience 20080409 |
| Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. | Alcoholism, clinical and experimental research 20080201 |
| The CRF-1 receptor antagonist, CP-154,526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice. | Alcoholism, clinical and experimental research 20080201 |
| The design, synthesis and structure-activity relationships of 1-aryl-4-aminoalkylisoquinolines: a novel series of CRF-1 receptor antagonists. | Bioorganic & medicinal chemistry letters 20080201 |
| Corticotropin releasing factor-1 receptor antagonist, CP-154,526, blocks the expression of ethanol-induced behavioral sensitization in DBA/2J mice. | Neuroscience 20071130 |
| Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms. | The Journal of pharmacology and experimental therapeutics 20071101 |
| Novel substituted tetrahydrotriazaacenaphthylene derivatives as potent CRF1 receptor antagonists. | Bioorganic & medicinal chemistry letters 20070915 |
| Effects of hypoxia on glucose, insulin, glucagon, and modulation by corticotropin-releasing factor receptor type 1 in the rat. | Endocrinology 20070701 |
| An arginine vasopressin V1b antagonist, SSR149415 elicits antidepressant-like effects in an olfactory bulbectomy model. | Progress in neuro-psychopharmacology & biological psychiatry 20070413 |
| Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression. | Pharmacology, biochemistry, and behavior 20070301 |
| CP-154,526, a CRF type-1 receptor antagonist, attenuates the cue-and methamphetamine-induced reinstatement of extinguished methamphetamine-seeking behavior in rats. | Psychopharmacology 20070201 |
| Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum. | Peptides 20060601 |
| The corticotropin-releasing factor (CRF)(1) receptor antagonists CP154,526 and DMP695 inhibit light-induced phase advances of hamster circadian activity rhythms. | Brain research 20060414 |
| Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. | Psychopharmacology 20060301 |
| Suppression of adrenocorticotrophic hormone secretion by simultaneous antagonism of vasopressin 1b and CRH-1 receptors on three different stress models. | Neuroendocrinology 20060101 |
| Corticotropin-releasing factor receptor 1 mediates acute and delayed stress-induced visceral hyperalgesia in maternally separated Long-Evans rats. | American journal of physiology. Gastrointestinal and liver physiology 20051001 |
| Effects of CP 154,526, a CRF1 receptor antagonist, on behavioral responses to cocaine in rats. | Neuropeptides 20051001 |
| Effects of corticotropin-releasing hormone receptor antagonists on cocaine-induced dopamine overflow in the medial prefrontal cortex and nucleus accumbens of rats. | Synapse (New York, N.Y.) 20050915 |
| Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050901 |
| Substituted tetraazaacenaphthylenes as potent CRF1 receptor antagonists for the treatment of depression and anxiety. | Bioorganic & medicinal chemistry letters 20050815 |
| Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonists. | Journal of medicinal chemistry 20050811 |
| Corticotropin-releasing factor receptor subtypes mediating nutritional suppression of estrous behavior in Syrian hamsters. | American journal of physiology. Regulatory, integrative and comparative physiology 20050801 |
| The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats. | Psychopharmacology 20050701 |
| Comparison of the effects of diazepam, the CRF1 antagonist CP-154,526 and the group II mGlu receptor agonist LY379268 on stress-evoked extracellular norepinephrine levels. | Neuropharmacology 20050601 |
| CRF receptor type 1 mediates continual hypoxia-induced CRF peptide and CRF mRNA expression increase in hypothalamic PVN of rats. | Peptides 20050401 |
| CRF1 receptor antagonist CP-154,526 reduces cardiovascular responses during acute psychological stress in rabbits. | Brain research 20040813 |
| Transcriptional regulation of the CART promoter in CATH.a cells. | Brain research. Molecular brain research 20040705 |
| Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release. | The European journal of neuroscience 20040701 |
| CRF-receptor 1 blockade attenuates acute posttraumatic hyperglycemia in rats. | The Journal of surgical research 20040601 |
| Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression. | European journal of pharmacology 20040525 |
| Delayed stress-induced colonic hypersensitivity in male Wistar rats: role of neurokinin-1 and corticotropin-releasing factor-1 receptors. | American journal of physiology. Gastrointestinal and liver physiology 20040401 |
| Effect of long-term blockade of CRF(1) receptors on exploratory behaviour, monoamines and transcription factor AP-2. | Pharmacology, biochemistry, and behavior 20040401 |
| Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors. | Neuropharmacology 20031001 |
| Extrahypothalamic corticotropin-releasing hormone mediates (-)-nicotine-induced elevation of plasma corticosterone in rats. | European journal of pharmacology 20030725 |
| Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes. | Journal of neurochemistry 20030301 |
| The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review. | CNS drug reviews 20030101 |
| CRF1-receptor antagonist CP-154526 reduces alerting-related cutaneous vasoconstriction in conscious rabbits. | Neuroscience 20030101 |
| 3-Aryl pyrazolo[4,3-d]pyrimidine derivatives: Nonpeptide CRF-1 antagonists. | Bioorganic & medicinal chemistry letters 20020819 |
| Peripheral CRF activates myenteric neurons in the proximal colon through CRF(1) receptor in conscious rats. | American journal of physiology. Gastrointestinal and liver physiology 20020501 |
| Potential role for the hypothalamo-pituitary-adrenal axis in the conditioned reinforcer-induced reinstatement of extinguished cocaine seeking in rats. | Psychopharmacology 20020501 |
| Brain pharmacokinetics of a nonpeptidic corticotropin-releasing factor receptor antagonist. | Drug metabolism and disposition: the biological fate of chemicals 20020201 |
| Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats. | American journal of physiology. Gastrointestinal and liver physiology 20020101 |
| 1-Alkyl-3-amino-5-aryl-1H-[1,2,4]triazoles: novel synthesis via cyclization of N-acyl-S-methylisothioureas with alkylhydrazines and their potent corticotropin-releasing factor-1 (CRF(1)) receptor antagonist activities. | Bioorganic & medicinal chemistry letters 20011217 |
| Effects of CP-154,526 on responding during extinction from cocaine self-administration in rats. | European journal of pharmacology 20011130 |
| Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2. | American journal of physiology. Regulatory, integrative and comparative physiology 20011101 |
| Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011001 |
| Role of brain arachidonic acid cascade on central CRF1 receptor-mediated activation of sympatho-adrenomedullary outflow in rats. | European journal of pharmacology 20010511 |
| Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats. | European journal of pharmacology 20010301 |
| Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20001101 |
| A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity. | European journal of pharmacology 19960808 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.